Annual Report 2019

Annual

Report 2019

Passionately supporting cancer patients for 25 years.

www.makna.org.my

MAKNA is a not-for-profit social enterprise registered under the Registrar of Societies in 1994. Lembaga Hasil Dalam Negeri: Subseksyen 44(6) Akta Cukai Pendapatan 1967.

RUJ: LHDN.01/35/42/52/179-6.4232 Nombor Warta Kerajaan 2153 bertarikh 30 Mac 1995.

MAKNA is aligned with four (4) of the United Nations’ Sustainable Development Goals (SDGs).

MAKNA is a member of the Union for International Cancer Control (UICC).

CONTENT 02

MISSION AND OBJECTIVE

11

VOLUNTEERS

03

MESSAGE FROM FOUNDER & PRESIDENT

12

CANCER AWARENESS

04

FOREWORD BY THE GENERAL MANAGER

13

CANCER RESEARCH

05

BOARD OF TRUSTEES

15

DONOR ACQUISITION

06

EXECUTIVE COMMITTEE

17

MAKNA - PPUKM CANCER INSTITUTE

07

DIGITAL MOBILE MAMMOGRAM UNIT

18

OTHER SERVICES

09

BURSARY PROGRAMME

19

GOING FORWARD, LOOKING AHEAD

10

HOME VISIT

24

FINANCIAL STATEMENT

01

MISSION To mobilise resources in order to provide curative, preventive, research and support services to cancer patients and families, high-risk groups and the general public, in Malaysia and the region.

OBJECTIVE To pool and utilise all efforts, expertise and finance from all sectors of the society to fight cancer and reduce related pain, morbidity and the suffering that cancer patients undergo.

02

MESSAGE FROM FOUNDER & PRESIDENT “Crazy people do crazy things and achieve crazy results”.

That is what I tell people when they do not believe that we can run a charity professionally.

I have achieved many things in life that I am very proud of; from fulfilling my dream of becoming a lawyer to having the chance of serving in the Cabinet of Malaysia. Yet, the one achievement which I will always hold so dearly to my heart is establishing MAKNA.

DATO’ MOHD FARID ARIFFIN

2019 marks MAKNA’s 25th anniversary. I have spent 25 years of my life to ensure that we will help as many cancer patients as possible to get the best treatment in the country.

Success demands hard work. We need to work hard and work smart. Although I have mentioned it countless times to the point that I may even sound like an old broken record, but believe me, everything will fall into its place should we embrace this principle. MAKNA is the embodiment of endless possibilities and success that we can achieve when we give it our all.

I am now in the twilight of my years. I still feel strong physically but my memory is slowly fading. Nevertheless, deep in my heart, my love for this organisation is unshakeable. It is my wish that MAKNA will continue to be a meaningful organisation to the society. With the unwavering trust and contributions from our donors, together with the sheer dedication of our staffs at MAKNA, I believe this is possible.

My doa to all is for a world where there is no sickness. Let’s heal it together, for a better future insya-Allah.

03

FOREWORD BY THE GENERAL MANAGER 2019 marks the 25th anniversary of MAKNA. It seems like only yesterday that we started our operations at Insas Berhad in Jalan Sultan Ismail.

Now, we have our own office at Jalan Ampang. Praise be to Allah and to all donors who have supported our work. Together, we can move mountains. It has been a meaningful 25 years of bringing the much needed service to cancer patients in the country.

As much as it is important for us to continue to serve the underprivileged community, it is equally vital for us to promote a stable and sustainable growth in our organisation. Only by doing so, we are able to maintain longevity. Additionally, we take serious effort in protecting the trust of our stakeholders and beneficiaries, which is why we seek to publish our annual reports as a method of practicing transparency and accountability.

FARAHIDA MOHD FARID

We are proud to share that in 2019: •

We successfully provided financial support to 5,320 cancer patients comprised of 4,994 adults and 326 children through our Bursary Programme.

•

Our Home Visit team met with 3,277 patients in 14 states across the country.

•

Our Digital Mobile Mammogram Unit travelled nationwide, performing 3,704 mammogram screenings including 2,442 clinical breast examinations.

I encourage you to find out more regarding the achievements of our various programs and services in 2019 in the following pages.

In addition, digitalisation is an area which we look to capitalise on. It shall allow for the mobilisation of people towards our purpose. As a social enterprise, improvement in the digital aspect is a must. This is due to the fact that it will also improve productivity and efficiency of the organisation which will ultimately translate into a lower operational cost.

We remain optimistic for a bright outlook in 2020. By utilizing digital technology as mentioned earlier, we believe it is possible. Our Digital Mobile Mammogram Unit will be expanding its services to East Malaysia to provide free screening especially in the rural areas. Plus, a new halfway house located in Putrajaya is set to be launched to accommodate patients receiving treatment at the National Cancer Institute.

By running and staying relevant for 25 years, MAKNA has stood the test of time. It indicates the fruitfulness of our organisation and that we are on the right track in our journey of helping cancer patients in Malaysia. With your endless support, we will continue to march onwards.

A final note of thanks to the Board of Trustees, Executive Committee and staffs of the large MAKNA family. Each and everyone’s effort is instrumental in the good results of 2019.

Thank you.

04

BOARD OF TRUSTEES

YAM Tengku Puteri Seri Lela Wangsa Pahang Tengku Tan Sri Hajjah Meriam Binti Sultan Haji Ahmad Shah DK., PSM., SIMP., JP.

YBhg Emeritus Professor Tan Sri Dato’ Dzulkifli Abdul Razak Chairperson, Rector, International Islamic University Malaysia

EXECUTIVE COMMITTEE

Vice President Emeritus Professor Dr Cheong Soon Keng Dean, Faculty of Medicine & Health Sciences UTAR & Emeritus Professor, Hospital Canselor Tuanku Muhriz

Honorary Secretary Dr Imran Abdul Khalid Hon. Lecturer, Penang Medical College & Chairman Badan Sokongan Pesakit Kanser Seberang Perai

05

Honorary Treasurer Rosleem Haji Nordin @ Bohari Senior Accountant, Accountant General’s Department of Malaysia

Member Professor Datin Paduka Dato’ Dr Aini Ideris Vice-Chancellor, Universiti Putra Malaysia

Member Dr Teoh Hoon Koon Assistant Professor, Faculty of Medicine & Health Sciences UTAR

Assistant Honorary Treasurer Douglas Tan Hock Kee Group Managing Director, Asian Business Solutions Group of Companies

Member Professor Abdul Aziz Baba Vice-Chancellor, Professor of Medicine, International Medical University Malaysia

Member Zainol Bahari Talib Vice Chairman, Takaful National Board, NAMLIFA

Assistant Honorary Secretary Farahida Mohd Farid General Manager, Majlis Kanser Nasional

Member Professor Dato’ Dr Hj Jafri Malin Datuk Hj Abdullah Director, Centre for Neuroscience Services and Research, Universiti Sains Malaysia Kampus Kesihatan & Professor of Neurosciences and Senior Consultant Neurosurgeon Hospital Universiti Sains Malaysia Kubang Kerian, Kelantan

Member Rohaizad Ismail CEO, KAF Investment Bank Berhad

06

DIGITAL MOBILE MAMMOGRAM UNIT

We believe that early detection and prevention are important in reducing cancer morbidity and mortality. With this in mind, MAKNA introduced the Digital Mobile Mammogram Unit Programme in 2011.

Total Mammogram

Year 2019

TOTAL SCREENING RURAL

URBAN POOR

CORPORATE

2019 : 2960

2019 : 638

2019 : 106

2018 : 4514

2019 : 3704 2018 : 5620

2018 : 377

2018 : 729

Screening by Age and Ethnicity : 266

43%

47

40-49

41% 50-59

1172

2219

MALAY CHINESE INDIAN

15%

OTHERS

60-69

07

DIGITAL MOBILE MAMMOGRAM UNIT

Digital Mobile Mammogram Unit Programme deliver breast cancer screening service to locations all over Malaysia, from districts to cities, from rural to urban poor dwellings, to those who are unable to afford or have access to such facility. By doing so, we aim to enable the detection of breast cancer at the early stages and help reduce breast cancer death rate.

Detected Abnormalities

NORMAL

ABNORMAL

CONFIRMED CASE

2019 : 1801

2019 : 94

2019 : 8

2018 : 4335

2018 : 11

2018 : 115

Total Clinical Breast Examinations :

MALE

FEMALE

2019 : 324

2019 : 2118

2018 : 851

2018 : 2796

98%

2%

NORMAL

ABNORMAL

TOTAL CASES 2019 : 2442 2018 : 3647

08

BURSARY PROGRAMME (FINANCIAL ASSISTANCE)

the Bursary Programme, cancer patients in the BURSARY PROGRAMME Under lower income groups who are undergoing treatment at government hospitals can apply to MAKNA for financial via the hospitals’ Medical Social Work (MSW) (FINANCIAL ASSISTANCE) aid Department. Financial aid is provided for purchasing

necessities that are recommended by their doctor which include non-formulary drugs, surgical equipment, prostheses, medical appliances and also monthly financial assistance for those who need it.

Year 2019

Total Assistance Cancer patient has to be undergoing or seeking treatment at any government hospitals.

ADULT CASES 2019 : 5114 2018 : 3992

PAEDIATRIC CASES 2019 : 330 2018 : 300

TOTAL CASES 2019 : 5444 2018 : 4292 AMOUNT DISBURSED

2019 : RM10,782,762.00 2018 : RM7,584,172.00

The Medical Officer will refer financially-challenged patients to the MSW Department for assistance.

MSW officers will then refer eligible cancer patients’ application to MAKNA through online MAKNA Bursary Online System-(MBOS).

Received application via MBOS will be verified by MAKNA Officer.

Application will be processed within 14 working days upon management’s approval.

The status of the approval then can be accessed via MBOS by MSW officers for further action.

Types of Assistance :

FINANCIAL ASSISTANCE

MEDICAL APPLIANCES

PROSTHESES

NON-FORMULARY DRUGS

SURGICAL EQUIPMENT

09

HOME VISIT

Year 2019

To ensure that donations are channeled to the rightful recipients, all patients assisted under the Bursary Programme are visited by our Home Visit Team. In addition, they are able to establish rapport with patients and better understand their conditions as well as socio-economic background. The team plays an essential role in providing emotional support and encouragement for patients to continue with their treatment or check-ups.

Total Visits PRE VISIT

ADULT PATIENTS

PAEDIATRIC PATIENTS

2019 : 3053

2019 : 224

2018 : 2727

2018 : 194

BURSARY DEPARTMENT

HOSPITALS

APPROVED BURSARY APPLICATIONS

POST VISIT

TOTAL CASES

2019 : 3277 2018 : 2921

HOSPITALS

BURSARY DEPARTMENT

LATEST STATUS

HOME VISIT TEAM

Home Visit Roles:

Assess and verify patients’ details, prognosis, treatment and socio-economic status to better administer disbursement of funds

Ensure patients receive the approved aid and continuing their treatment

Help patients and family gain better knowledge on MAKNA services

10

VOLUNTEERS

Year 2019

Our volunteers are the key driving force which help us cast a wider net and extend support to a larger group of cancer patients as they undergo treatment; encompassing communities from all parts of the country. Some of the volunteers are cancer survivors themselves and this allows them to help other cancer patients by sharing their own experiences and struggles surviving cancer.

Total Volunteers

LEADERS

POTENTIAL LEADERS

2019 : 32

2019 : 97 2018 : 81

2018 : 27

ACTIVE TOTAL ACTIVITIES CONDUCTED

2019 : 430 2018 : 300

2019 : 566 2018 : 414

Main Functions:

VOLUNTEER TRAININGS

FUNDRAISING & CANCER AWARENESS

HOME & HOSPITAL VISITS

VOLUNTEER SUPPORT GROUPS

COMMUNITY OUTREACH PROGRAMME

11

CANCER AWARENESS Year 2019

Another key objective of MAKNA is to help reduce cancer incidences in Malaysia through continuous education to drive awareness and encourage positive health behavior changes. Our Exhibition team organizes talks and exhibitions on a yearly basis in addition to regular demonstrations and more in local communities, corporate sector, government agencies, institutions of higher learning and schools.

Total Exhibition

2019

2018

GOVERNMENT AGENCIES

15

44

UNIVERSITIES

21

24

CORPORATES

21

40

COMMUNITIES

28

34

TOTAL

142 12

CANCER RESEARCH Year 2019

For the past 18 years, we have committed towards advancing cancer research in providing research funds and grants to make life-changing scientific discoveries. As of 2019, RM12 million has been allocated to fund cancer research through 20 collaborative efforts in which 83 research topics have been initiated with various higher learning institutions and research institutes.

Collaborations Graduates produced from research collaboration projects

RESEARCH PROJECTS

83

PROJECTS COMPLETED

56

PhDs

MSCs

BSC

21

69

2

Project Categories:

PRE-CLINICAL

BASIC

EPIDEMIOLOGY

HEALTH POLICY & OUTCOME

PUBLIC HEALTH

Provides results applicable to prevention, diagnosis or treatment of cancer, and rehabilitation of cancer patients, but not ready for use in human

Seeks to answer fundamental questions about development and nature of cancer

Investigates circumstances under which cancer occurs in populations

Investigates creation and effects of laws and public policies affecting people making health decisions related to cancer control

Public health and nutrition studies

13

CANCER RESEARCH

The MAKNA Cancer Research Award, initiated in collaboration with the Academy of Sciences Malaysia, aims to promote cancer research among young scientists.

Through such funding and grants, we are hoping to make a positive impact to the future of cancer research.

Malaysian Stem Cell Registry MALE

2019 : 36.7% 2018 : 31.2%

New registered stem cell donors

1 In collaboration with Ministry of Health Malaysia and The Institute for Medical Research

FEMALE

2019 : 2047

2019 : 63.3% 2018 : 68.6%

2018 : 1846

No. of Search, Match and Transplants 176

Search

163

158

Match Transplant

157

YEAR 2019 TOTAL

140

SEARCH

111 95

96

176

90

MATCH 46 35

40

33

32

23

39

31

26

23

TRANSPLANT

1

2

0

3

3

1

4

0

2

2010

2011

2012

2013

2014

2015

2016

2017

2018

0

14

DONOR ACQUISITION Year 2019

Our donors’ support and generosity made it possible for us to stay true to our mission to reduce the burden of cancer patients. Together, we are saving lives through the continuous effort of fund raising and enhancing the life of cancer patients.

My Pledge Against Cancer Direct Debit Donor Programme

This fund raising project has been the main income generator for MAKNA since 2002. Each donor commits to MAKNA a monthly deduction of RM38, RM58 or RM88. The donation is made via credit cards, debit cards or bank accounts.

Monthly Commitment

Auto Debit

RM38 - RM88

New Donors

Anniversary Donors

Amount Collected

2019 : 13,460

2019 : 85,693

2019 : RM41.25 million

2018 : 12,741

2018 : 92,268

2018 : RM37.13 million

15

DONOR ACQUISITION Year 2019

Making a donation has never been easier. Our donors can now contribute through the Sen Saves Lives (SSL) program, donation boxes or electronically via e-Charity platforms.

Sen Saves Lives (SSL)

The initiatives under SSL include Kempen Kutip Syiling and donation boxes. This programme is supported by the Ministry of Education and Bank Negara Malaysia to encourage participation of the younger generation. Additionally, donation boxes are located in selected premises for the public.

Amount Collected

2019 : RM155,778.49 2018 : RM244,308.31

Year 2019

e-Charity:

Donors are able to make online donations via credit cards or online banking payment at www.makna.org.my, or crowdfund via peoplegiving.org, simplygiving.com and globalgiving.org.

MAKNA bank accounts for e-Charity: Bank Rakyat : 220621275301 Billplz (CIMB) : 8001183431 PayPal (CIMB) : 8001183431 SimplyGiving (Maybank) : 514075001920 People Giving (Maybank) : 514075001920

Amount Collected

2019 : RM356,006.90 2018 : RM403,122.68

16

MAKNA - HCTM CANCER INSTITUTE Year 2019

The cancer institute, established in 1999 in collaboration with Hospital Canselor Tuanku Muhriz UKM (HCTM), provides comprehensive and state-of-the-art facilities to cancer patients of all financial background. The cancer institute comprises of an oncology ward, radiotherapy services centre and a stem cell transplant ward.

Total Patients 2019 : 974

2019 : 92

2018 : 838

2018 : 124 STEM CELL TRANSPLANT WARD

ONCOLOGY WARD

2019 : 58

2019 : 12

2018 : 62

2018 : 19

RADIOTHERAPY

2019 : 238

2019 : 42

2018 : 145

2018 : 41 PALLIATIVE

CHEMOTHERAPY

BRACHYTHERAPY

BONE MARROW TRANSPLANT

2019 : 25

2019 : 559

2018 : 23

2018 : 497 SYMPTOMATIC

17

CANCER HELPLINE

We are always here to listen and give support, not only to cancer patients, but also their families, caregivers and the general public. Our personnel who are trained in oncology will attend to the helpline and emails seeking information, guidance and emotional support.

Calls attended: 4920 Emails replied: 1634

CANCER SUPPORT GROUP

Battling with cancer is already hard; dealing with the emotional toll of cancer can also be overwhelming. Our support group headed by trained staffs and volunteers will give counsel to cancer patients, their family members or caregivers to ease their cancer journey.

Members meet to share their personal experiences, exchange information, and gain insight into how others cope with their condition and the problems they encountered.

Sharing therapy sessions: 67 sessions Visits to patients at home and hospitals: 126 visits

YOUNG CANCER SURVIVOR SCHOLARSHIP

For young cancer patients/survivors, their studies might be affected as a lot of resources are allocated for their treatment. To help them complete their education, we provide financial assistance through this scholarship programme.

Total amount: RM13,362.00 Total application: 10 applications

HALFWAY HOUSE

Our halfway houses provide short-term accommodation for patients and their caregivers travelling away from home for treatment. Patients can have a comfortable stay to rest after undergoing the treatment without having to worry about the cost of travel.

Total patients assisted: 125

GOING FORWARD, LOOKING AHEAD

COMING SOON

COMING SOON

Halfway House in Cheras

Exhibition Truck

COMING SOON Halfway House in Gombak

LAUNCHING SOON Halfway House in Putrajaya

19

MAKNA IN HANOI, VIETNAM

Partners:

Address: Room 1003, Ford Thang Long building, 105 Lang Ha Street, Dong Da District, Hanoi, Vietnam.

Email: international@makna.org.my

Bright Future Fund, Ministry of Health, Vietnam Hung Viet Oncology Hospital National Cancer Hospital (K Hospital) Hanoi Oncology Hospital

Community outreach projects:

Supporters & Volunteers:

Homecare visit Emotional support for cancer patients in Hanoi K hospital Cancer awareness and education events

Hanoi Medical University Electric Power University Centre for Research – Consulting and Support of Community Health (RCSCH) Cancer Survivor Groups

COMING SOON Digital Mobile Mammogram Unit in Sabah

LAUNCHING SOON Digital Mobile Mammogram Unit in Sarawak

20

ACTING TOGETHER, TO FIGHT CANCER

FINANCIAL STATEMENTS 2019

CONTENT 24 25 28

STATEMENT BY EXECUTIVE COMMITTEE MEMBERS

REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS STATEMENT OF INCOME AND EXPENDITURE

29

STATEMENT OF ASSETS, LIABILITIES AND FUND BALANCES

30

STATEMENT OF CHANGES IN ACCUMULATED FUND

31 33

STATEMENT OF CASH FLOWS NOTES TO THE FINANCIAL STATEMENTS

STATEMENT BY EXECUTIVE COMMITTEE MEMBERS We, Dato’ Mohd Farid Ariffin and Rosleem Nordin @ Bohari, two of the Executive Committee members of Majlis Kanser Nasional, state that, in the opinion of the Executive Committee, the financial statements set out on pages 28 to 41 are drawn up so as to give a fair presentation of the financial position of the Society as at 31 December 2019 and of the financial performance and cash flows of the Society for the financial year ended on the date in accordance with the accounting policies set out in Note 2 to the financial statements.

DATO’ MOHD FARID ARIFFIN PRESIDENT

ROSLEEM NORDIN @ BOHARI HONORARY TREASURER

Kuala Lumpur

24

REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS Our opinion In our opinion, the financial statements of Majlis Kanser Nasional (the “Society”) give a true and fair view of the financial position of the Society as at 31 December 2019, and of its financial performance and its cash flows for the financial year then ended in accordance with the accounting policies set out in Note 2 to the financial statements.

What we have audited We have audited the financial statements of the Society, which comprise the statement of assets, liabilities and fund as at 31 December 2019, and the statement of income and expenditure, statement of changes in accumulated fund and cash flow statement for the financial year then ended, and notes to the financial statements, including a summary of significant accounting policies, as set out on pages 28 to 41.

Basis for opinion We conducted our audit in accordance with approved standards on auditing in Malaysia and International Standards on Auditing. Our responsibilities under those standards are further described in the “Auditors’ responsibilities for the audit of the financial statements” section of our report.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Independence and other ethical responsibilities We are independent of the Society in accordance with the By-Laws (on Professional Ethics, Conduct and Practice) of the Malaysia Institute of Accountants (“By-Laws) and the International Ethics Standards Board for Accountants’ Code of Ethics for Professional Accountants (“IESBA Code”), and we have fulfilled our other ethical responsibilities in accordance with the By-Laws and the IESBA Code.

Responsibilities of the Executive Committee Members for the financial statements The Executive Committee Members (“the Committee”) if the Society is responsible for the preparation of the financial statements of the Society that give a true and fair view in accordance with the accounting policies set out in Note 2 to the financial statements. The Committee is also responsible for such internal control as the Committee determines is necessary to enable the preparation of financial statements of the Society that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements of the Society, the Committee is responsible for assessing the Society’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Committee either intends to liquidate the Society or to cease operations or has no realistic alternative but to do so.

25

REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS

(CONTINUED)

Auditor’s responsibilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial statements of the Society as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is high level of assurance, but it is not a guarantee that an audit conducted in accordance with approved standards on auditing in Malaysia and International Standards on Auditing will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

As part of an audit in accordance with approved standards on auditing in Malaysia and International Standards on Auditing, we exercise professional judgment and maintain professional skepticism throughout the audit. We also: (a) Identify and asses the risks of material misstatement of the financial statements of the Society, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. (b) Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Society’s internal control (c) Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Committee. (d) Conclude on the appropriateness of the Committee’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Society’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the financial statements of the Society or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Society to cease to continue as a going concern.

26

REPORT ON THE AUDIT OF THE FINANCIAL STATEMENTS

(CONTINUED)

(e) Evaluate the overall presentation, structure and content of the financial statements of the Society, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with the Committee regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

OTHER MATTERS This report is made solely to the members of the Society and for no other purpose. We do not assume responsibility to any other person for the content of this report.

PRICEWATERHOUSECOOPERS PLT LLP0014401-LCA & AF 1146 Charted Accountants Kuala Lumpur 30 July 2020

27

STATEMENT OF INCOME AND EXPENDITURE FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 NOTES INCOME Receipts from projects Donation received from individuals, societies and corporations Interest from deposits Dividend income Annual subscriptions Other income

3

2019

2018

RM

RM

44,982,583 361,697 4,534,314 175,103 2,780 300

41,711,482 158,868 3,873,786 313,146 3,170 553

50,056,777

46,061,005

10,782,762 11,946,915 11,386,540 816,280 569,108 239,727 13,362 (467,584)

7,584,172 10,818,924 11,039,926 1,035,203 531,748 377,845 1,003,399

35,287,110

32,391,217

14,769,667

13,669,788

(25)

(264)

14,769,642

13,669,524

LESS: EXPENDITURE Bursary Salaries and related costs Activities costs Administrative costs Depreciation of property, plant and equipment Consumables, cleaning and utilities Scholarship granted (Reversal of)/provision for impairment of investments

SURPLUS OF INCOME OVER EXPENDITURE BEFORE TAXATION TAXATION SURPLUS OF INCOME OVER EXPENDITURE AFTER TAXATION

28

STATEMENT OF ASSETS, LIABILITIES AND FUND BALANCES AS AT 31 DECEMBER 2019

NOTES

2019

2018

RM

RM

6

9,899,393

9,261,538

7 8

7,808,092 2,059,411 20,275 110,527,104 9,069,402

7,167,211 1,779,913 18,494 100,325,621 6,339,208

129,484,284

115,630,447

3,412,330

3,690,280

NET CURRENT ASSETS

126,071,954

111,940,167

NET ASSETS

135,971,347

121,201,705

135,971,347

121,201,705

NON-CURRENT ASSETS Property, plant and equipment CURRENT ASSETS Investments Receivables Tax recoverable Fixed deposits with licensed banks Cash and bank balances

9 9

CURRENT LIABILITIES Trade and other payables

10

Financed by: ACCUMULATED FUND Accumulated surplus of income over expenditure

29

STATEMENT OF CHANGES IN ACCUMULATED FUND

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019

TOTAL 2019

RM

Balance at 1 January 2019 Surplus of income over expenditure

121,201,705 14,769,642

Balance at 31 December

135,971,347

2018 Balance at 1 January 2018 Surplus of income over expenditure

107,532,181 13,669,524

Balance at 31 December 2018

121,201,705

30

STATEMENT OF CASH FLOWS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 2019

2018

RM

RM

CASH FLOWS FROM OPERATING ACTIVITIES Surplus of income over expenditure after taxation

14,769,642

13,669,524

Adjustment for: Depreciation of property, plant and equipment Gain on disposal of property, plant and equipment Interest income Dividend income Tax expense Provision for impairment of receivables (Reversal of)/provision for impairment of investment

569,108 (4,534,314) (175,103) 25 (467,584)

531,748 (554) (3,873,786) (313,146) 264 199,317 1,003,399

10,161,774

11,216,766

Changes in working capital: Receivables Trade and other payables

(277,692) (277,950)

(330,793) 1,184,268

Cash generated from operating activities

9,606,132

12,070,241

Interest received Tax paid Tax refund

4,164,480 (1,806) -

3,586,133 (5,921) 20,364

13,768,806

15,670,817

Purchase of property, plant and equipment Proceeds from disposal of property, plant and equipment Net movement in fixed deposits with licensed banks with maturity of more than 3 months Dividend received Reinvestment of dividend income into investments in unit trusts

(1,206,963) -

(759,781) 3,687

(9,831,649) 173,297

(15,970,471) 307,921

(173,297)

(99,700)

Net cash flows used in investing activities

(11,038,612)

(16,518,344)

Surplus before working capital changes

Net cash flows generated from operating activities CASH FLOWS FROM INVESTING ACTIVITIES

31

STATEMENT OF CASH FLOWS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED) NOTES

Net increase/(decrease) in cash and cash equivalents Cash and cash equivalents at beginning of the financial year Cash and cash equivalents at end of the financial year

9

2019

2018

RM

RM

2,703,194

(847,527)

6,339,208

7,186,735

9,069,402

6,339,208

Non-cash transactions: During the financial year, dividend income of RM173,297 (2018: RM99,700) had been reinvested in investments in unit trusts and tax payment of RM1,806 (2018: RM5,224) had been deducted from the gross dividend income.

32

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019

1. CONSTITUTION Majlis Kanser Nasional ("MAKNA") was registered on 10 November 1994 and officially launched on 30 March 1995 and was approved by the Department of Inland Revenue for the purposes of Section 44(6) of the Income Tax Act, 1967. The objectives of Majlis Kanser Nasional are to work towards the attainment of a better health care system for all Malaysians especially in terms of the prevention and control of cancer; to develop and formulate policies for cancer prevention and intervention; to strengthen and generate services and programmes on cancer and to strengthen support services for cancer patients and affected persons.

MAKNA has 211 (2018: 181) employees at the end of the financial year.

The address of the principal place of activity is as follows: BG 03A & 05, Ground Floor Megan Ambassy, 225, Jalan Ampang 50450, Kuala Lumpur.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (a) Property, plant and equipment Property, plant and equipment are stated at cost, with the amount of sales and services tax (“SST”) included, less accumulated depreciation and impairment losses.

Property, plant and equipment are depreciated on a straight line basis to write-off the cost of each asset over its expected useful life. The principal annual rates of depreciation used are as follows: Building Office renovation Hospital renovation Office equipment Hospital equipment Computer equipment Exhibition equipment Furniture and fittings Mobile trailer Motor vehicle

2.0% 20.0% - 33.3% 20.0% 20.0% 20.0% 20.0% 20.0% 20.0% 20.0% 20.0%

Property, plant and equipment received on donation are not capitalised.

At each balance sheet date, an assessment is made for any indication of impairment. If such indications exist, an analysis is performed to assess whether the carrying amount of the asset is fully recoverable. A write down is made if the carrying amount exceeds the recoverable amount. See accounting policy Note 2 (e) on impairment of assets.

33

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED) 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) (b) Cash and cash equivalents Cash and cash equivalents consist of cash in hand, cash at bank and fixed deposits with licensed banks with original maturities of 3 months or less that are readily convertible to known amounts of cash which are subject to an insignificant risk of change in value. (c) Income and expenditure Income is recognised when it is probable that the economic benefits associated with the transaction will flow to the organisation and the amount of income can be measured reliably.

Receipts from projects Receipts from projects relate to donations raised from projects and are recognised on a receipt basis.

Donation received from individuals, societies and corporations Donation received from individuals, societies and corporations are recognised on a receipt basis.

Interest from deposits with licensed banks Interest from deposits with licensed banks is recognised on an accrual basis based on the principal outstanding and the rates applicable.

Interest from investment Interest from investment is recognised on an accrual basis based on the principal outstanding and the rates applicable.

Dividend income Dividend income is recognised when the right to receive payment is established.

Expenditure is recognised on an accrual basis. (d) Investments Investments are stated at lower of cost or market value on an aggregate portfolio basis. On disposal of an investment, the difference between the net disposal proceeds and its carrying amount is charged or credited to the statement of income and expenditure.

Investments are classified as current assets if maturity is due within one year or less. If not, they are presented as non-current assets.

34

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) (e) Impairment of assets Property, plant and equipment are reviewed for impairment losses whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Impairment loss is recognised for the amount by which the carrying amount of the asset exceeds its recoverable amount.

The recoverable amount is the higher of an asset’s net selling price and value in use. For the purpose of assessing impairment, assets are grouped at the lowest level for which there are separately identifiable cash flows. The impairment loss is charged to the statement of income and expenditure and any subsequent increase is recognised in the statement of income and expenditure. (f) Receivables Receivables are measured initially at cost, with the amount of sales and service tax (“SST”) included, less provision for impairment. The provision is established when there is objective evidence that the Society will not be able to collect the amounts due according to the original terms of receivables. Cash flows are included in the statement of cash flows on a gross basis. (g) Payables Payables are obligations to pay for goods and services that have been acquired in the ordinary course of operation from suppliers. Payables are recognised at cost, with the amount of sales and service tax (“SST”) included. Cash flows are included in the statement of cash flows on a gross basis. (h) Income taxes Current tax expense is determined according to the tax laws of each jurisdiction in which the Society operates and include all taxes based upon the taxable income.

35

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED)

3. RECEIPTS FROM PROJECTS Donation received from projects: - Direct Debit Donor System - MAKNA Pledge against Cancer - Zakat - E-Charity - Sens Saves Lives - Mobile Project - Exhibition/ Pameran - Lifeline Clothing - Volunteers - Klimb for Kanser - Payroll Giving - Direct Mail - Merchandise & Home Visit - Telemarketing - International donors - Movember - AirAsia - Jom Botak - Ad-hoc - Others

4. EXPENDITURE Included in expenditure are: Salaries and related costs Audit remuneration Legal fees Provision for impairment of receivables

2019

2018

RM

RM

35,954,527 6,320,851 1,467,500 356,007 155,778 124,900 113,316 104,392 87,197 82,518 79,232 74,352 27,485 18,286 12,362 1,661 926 432 861

32,711,190 5,600,004 1,440,300 403,123 244,308 174,075 170,260 126,218 37,001 45,507 84,381 141,877 20,067 18,826 115,186 319,100 7,676 47,569 4,814

44,982,583

41,711,482

2019

2018

RM

RM

11,946,915 30,000 15,370 -

10,818,924 20,000 14,802 199,317

8,954,060 1,062,662 1,930,193

8,355,668 983,950 1,479,306

11,946,915

10,818,924

The employee information is as follow: Salaries and wages Contribution to Employees’ Provident Fund Other employee benefits

36

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED) 5. TAXATION MAKNA has been given exemption on income, other than dividend income, under Paragraph 13 of Schedule 6 of the Income Tax Act, 1967 with effect from 1 January 2001. The taxation charge for the financial year is in respect of dividend income. There is no taxation charge on the income of the Society arising from its operations which is exempted from taxation under the mutuality concept.

2019 2018 RM

RM

25

264

Additions

Disposals

Cost at 31.12.2019

RM

RM

4,575,849 410,425 134,547 190,155 134,650 390,378 608,123 2,631,470 3,865,008 891,394

42,647 36,485 27,200 125,851 35,746 6,450 932,584 -

-

4,575,849 453,072 171,032 190,155 161,850 516,229 643,869 2,637,920 4,797,592 891,394

13,831,999

1,206,963

-

15,038,962

Charge for the year

Disposals

Accumulated depreciation 31.12.2019

RM

RM

573,529 95,258 74,377 79,261 34,903 258,010 308,904 2,525,890 620,329

91,517 86,055 25,124 31,266 28,743 55,261 109,617 26,609 114,916

-

665,046 181,313 99,501 110,527 63,646 313,271 418,521 2,552,499 735,245

4,570,461

569,108

-

5,139,569

Tax expense: Current year 6. PROPERTY, PLANT AND EQUIPMENT Cost at 1.1.2019

RM Building Office renovation Office equipment Hospital equipment Exhibition Equipment Computer equipment Furniture and fittings Mobile trailer Capital work in progress Motor vehicle

Accumulated depreciation 1.1.2019

RM Building Office renovation Office equipment Hospital equipment Exhibition Equipment Computer equipment Furniture and fittings Mobile trailer Motor vehicle

Net book value

RM

RM

9,899,393

37

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED)

6. PROPERTY, PLANT AND EQUIPMENT (CONTINUED) Cost at 1.1.2018

2018 Building Office renovation Office equipment Hospital equipment Exhibition equipment Computer equipment Furniture and fittings Mobile trailer Capital work in progress Motor vehicle

Additions

Disposals

Cost at 31.12.2018

RM

RM

4,575,849 232,620 102,383 189,735 88,810 320,593 554,356 2,499,500 3,620,800 891,394

177,805 32,164 1,257 45,840 69,785 56,752 131,970 244,208 -

(837) (2,985) -

4,575,849 410,425 134,547 190,155 134,650 390,378 608,123 2,631,470 3,865,008 891,394

13,076,040

13,831,999

RM

Accumulated depreciation 1.1.2018

759,781

(3,822)

Charges for the year

Disposals

Accumulated depreciation 31.12.2018

482,012 26,636 54,026 44,945 13,321 208,635 210,693 2,493,722 505,412 4,039,402

91,517 68,622 20,351 34,358 21,582 49,375 98,858 32,168 114,917 531,748

(42) (647) (689)

573,529 95,258 74,377 79,261 34,903 258,010 308,904 2,525,890 620,329 4,570,461

RM

Building Office renovation Office equipment Hospital equipment Exhibition equipment Computer equipment Furniture and fittings Mobile trailer Motor vehicle Net book value

RM

RM

RM

RM

9,261,538

MAKNA has 40,468.6 square metres of donated leasehold land in Mukim Bentong, Pahang under a 99 years lease period from 2 February 1999 to 1 February 2098 which has not been capitalised in the financial statements. The land cannot be transferred, leased or mortgaged and can only be used for commercial building purposes.

38

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED)

2019

2018

RM

RM

9,096,014 (1,287,922)

8,922,717 (1,755,506)

7,808,092

7,167,211

7,808,092

7,167,211

2019

2018

RM

RM

316,868 (206,652) 110,216

568,152 (206,652) 361,500

218,302 15,147 71,877 1,643,870

71,560 23,359 49,459 1,274,035

2,059,411

1,779,913

At 1 January Provision for the financial year

206,652 -

7,335 199,317

At 31 December

206,652

206,652

7. INVESTMENTS Quoted unit trusts: Cost Provision for impairment Market value: Quoted unit trusts 8. RECEIVABLES Debtors Less: Provision for impairment Prepayments Cash advances Deposits Accrued interest income

Movement in provision for impairment:

39

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED)

2019

2018

9. CASH AND CASH EQUIVALENTS

RM

RM

Fixed deposits with licensed banks Cash and bank balances

110,527,104 9,069,402 119,596,506

100,325,621 6,339,208 106,664,829

(110,527,104)

(100,325,621)

9,069,402

6,339,208

Less: Investment in fixed deposits with licensed banks with maturity more than 3 months Cash and cash equivalents

The weighted average interest rate per annum of fixed deposits with licensed banks effective as at the financial year end is 4.13% (2018: 4.34%) per annum. Fixed deposits have an average maturity period of 12 to 24 months (2018: 3 to 12 months). Bank balances are deposits held at call with banks.

10. TRADE AND OTHER PAYABLES

Trade payables Other payables and accruals

11. FINANCIAL ASSISTANCE COMMITMENT

Financial assistance commitment

2019

2018

RM

RM

2,834,656 577,674

2,842,807 847,473

3,412,330

3,690,280

2019

2018

RM

RM

742,600

885,350

As at 31 December 2019, the Society is committed to provide financial assistance to patients.

The number of months committed is within the range of 6 to 12 months, for an amount of RM150 to RM500 per month (2018: RM150 to RM500 per month).

40

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 (CONTINUED)

12. CAPITAL COMMITMENT Mammography machine Semi trailer

2019

2018

RM

RM

700,000 -

1,484,000 254,000

700,000

1,738,000

On 1 March 2016, the Society engaged Eemed International Sdn Bhd (“the Contractor”) to obtain on its behalf, from GE Healthcare Sdn Bhd 2 units of GE Senographe CARE Mamography machines. The balance due on this agreement as at 31 December 2019 is RM700,000 (2018: RM1,484,000).

On 1 March 2016, the Society also committed under an agreement entered with the Contractor for the commissioning of the two mobile screening units in 2 semi trailers. The balance due on this agreement as at 31 December 2019 is NIL (2018: RM254,000).

41

SOCIAL IMPACT Here’s an overview of MAKNA’s social impact throughout our 25 years of existence.

Bursary Programme (Financial Assistance)

5821

approved

58,849 cases

pediatric patients

53, 028

Home Visit

14 states visited

RM120,036,550.13

total assistance

adult patients

patients

32,436 visited

MAKNA - HCTM

128

20,374

stem cell harvesting

patients admitted male: 9958 female: 10,416

Cancer Helpline

4894 1624

peripheral blood

308 stem cell transplant

media 130 social messages

Digital Mobile Mammogram Unit

33

confirmed breast cancer cases via mammogram screening

breast 21,063 clinical examinations (CBE) done for women below 45 years or unable to do screenings

32,168

12

mammogram screenings done in 2019

emails

calls

states for mammogram screenings and CBE

MOBILE MAMMOGRAM

Cancer Research Pre-clinical research Basic research Public health & nutrition research Health, policy & outcome Epidemiological research

46 21 9 2 2

Education and Awareness

890

total exhibitions

13 states covered

Halfway Houses admitted 392 patients Kubang Kerian, Kelantan

Likas, Sabah

Kepala Batas, Penang

Kuching, Sarawak

Johor Bahru, Johor

5

halfway houses in total

(Majlis Kanser Nasional/National Cancer Council) BG 03A & 05, Ground Floor, Megam Ambassy, No 225, Jalan Ampang, 50450 Kuala Lumpur, Malaysia Telefon: +603-2162 9178 Faksimili: +603-216 29203 Email: makna@makna.org.my